
Biocon Limited has informed the Exchange regarding a press release dated September 06, 2023, titled "Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars Business In North America, Ahead of Schedule".
Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated September 06, 2023, titled "Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars Business In North America, Ahead of Schedule".
6ix hasn’t read this filing yet.
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon